nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxyurea—brain cancer—ocular cancer	0.443	0.531	CtDrD
Hydroxyurea—head and neck cancer—ocular cancer	0.392	0.469	CtDrD
Hydroxyurea—Reticulocytopenia—Dactinomycin—ocular cancer	0.0251	0.447	CcSEcCtD
Hydroxyurea—Radiation injury—Dactinomycin—ocular cancer	0.00827	0.147	CcSEcCtD
Hydroxyurea—Recall phenomenon—Dactinomycin—ocular cancer	0.005	0.0892	CcSEcCtD
Hydroxyurea—RRM2—G1/S-Specific Transcription—CDC25A—ocular cancer	0.00361	0.0332	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S-Specific Transcription—TFDP1—ocular cancer	0.00353	0.0324	CbGpPWpGaD
Hydroxyurea—RRM2—E2F mediated regulation of DNA replication—CDC25A—ocular cancer	0.00212	0.0195	CbGpPWpGaD
Hydroxyurea—RRM2—E2F mediated regulation of DNA replication—TFDP1—ocular cancer	0.00208	0.0191	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—CDKN2C—ocular cancer	0.00207	0.0191	CbGpPWpGaD
Hydroxyurea—Myelosuppression—Dactinomycin—ocular cancer	0.00185	0.033	CcSEcCtD
Hydroxyurea—RRM1—E2F transcription factor network—E2F5—ocular cancer	0.00172	0.0159	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—CDKN2C—ocular cancer	0.00171	0.0157	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—E2F4—ocular cancer	0.00169	0.0155	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—MYBL2—ocular cancer	0.00169	0.0155	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S-Specific Transcription—E2F1—ocular cancer	0.00169	0.0155	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—RBL1—ocular cancer	0.00166	0.0152	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—E2F2—ocular cancer	0.00166	0.0152	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—RBL2—ocular cancer	0.00152	0.014	CbGpPWpGaD
Hydroxyurea—Febrile neutropenia—Dactinomycin—ocular cancer	0.00144	0.0257	CcSEcCtD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—E2F2—ocular cancer	0.00144	0.0132	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—RBBP4—ocular cancer	0.00144	0.0132	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—E2F3—ocular cancer	0.00144	0.0132	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—E2F5—ocular cancer	0.00142	0.0131	CbGpPWpGaD
Hydroxyurea—Eruption—Dactinomycin—ocular cancer	0.00141	0.0251	CcSEcCtD
Hydroxyurea—RRM2—E2F transcription factor network—E2F4—ocular cancer	0.00139	0.0128	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—MYBL2—ocular cancer	0.00139	0.0128	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—CDC25A—ocular cancer	0.00137	0.0126	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—E2F2—ocular cancer	0.00136	0.0125	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—RBL1—ocular cancer	0.00136	0.0125	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—TFDP1—ocular cancer	0.00134	0.0123	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—RBL2—ocular cancer	0.00125	0.0115	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—E2F3—ocular cancer	0.00125	0.0115	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—RBBP4—ocular cancer	0.00125	0.0115	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—CCND3—ocular cancer	0.00121	0.0111	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—CDC25A—ocular cancer	0.00119	0.0109	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—E2F2—ocular cancer	0.00119	0.0109	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—RBBP4—ocular cancer	0.00118	0.0109	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—E2F3—ocular cancer	0.00118	0.0109	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—TFDP1—ocular cancer	0.00116	0.0107	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—CDC25A—ocular cancer	0.00113	0.0103	CbGpPWpGaD
Hydroxyurea—Hepatotoxicity—Dactinomycin—ocular cancer	0.00112	0.02	CcSEcCtD
Hydroxyurea—RRM2—E2F transcription factor network—TFDP1—ocular cancer	0.0011	0.0101	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—CCND3—ocular cancer	0.00105	0.00967	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDKN2C—ocular cancer	0.00104	0.0096	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—RBBP4—ocular cancer	0.00103	0.00945	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—E2F3—ocular cancer	0.00103	0.00945	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—CCND3—ocular cancer	0.000997	0.00917	CbGpPWpGaD
Hydroxyurea—RRM2—E2F mediated regulation of DNA replication—E2F1—ocular cancer	0.000992	0.00912	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—CDC25A—ocular cancer	0.000978	0.00899	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—TFDP1—ocular cancer	0.000956	0.00879	CbGpPWpGaD
Hydroxyurea—Ulcer—Dactinomycin—ocular cancer	0.000917	0.0163	CcSEcCtD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—E2F5—ocular cancer	0.000869	0.00798	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—CCND3—ocular cancer	0.000867	0.00797	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—E2F4—ocular cancer	0.000851	0.00782	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—MYBL2—ocular cancer	0.000851	0.00782	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—E2F2—ocular cancer	0.000835	0.00767	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—RBL1—ocular cancer	0.000835	0.00767	CbGpPWpGaD
Hydroxyurea—Infection—Carboplatin—ocular cancer	0.000828	0.0148	CcSEcCtD
Hydroxyurea—RRM2—G1/S Transition—CDC25A—ocular cancer	0.000817	0.00751	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S Transition—TFDP1—ocular cancer	0.000798	0.00734	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—CDK6—ocular cancer	0.000784	0.00721	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.000783	0.0072	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—HDAC1—ocular cancer	0.000776	0.00713	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.000768	0.00706	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—RBL2—ocular cancer	0.000766	0.00704	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—RBBP4—ocular cancer	0.000724	0.00665	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—E2F3—ocular cancer	0.000724	0.00665	CbGpPWpGaD
Hydroxyurea—Pain—Carboplatin—ocular cancer	0.000713	0.0127	CcSEcCtD
Hydroxyurea—RRM2—E2F mediated regulation of DNA replication—RB1—ocular cancer	0.000703	0.00647	CbGpPWpGaD
Hydroxyurea—Hepatic failure—Dactinomycin—ocular cancer	0.000701	0.0125	CcSEcCtD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDC25A—ocular cancer	0.000688	0.00633	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—HDAC1—ocular cancer	0.000674	0.0062	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—TFDP1—ocular cancer	0.000673	0.00618	CbGpPWpGaD
Hydroxyurea—Body temperature increased—Carboplatin—ocular cancer	0.000659	0.0117	CcSEcCtD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—CDK6—ocular cancer	0.000646	0.00594	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—HDAC1—ocular cancer	0.000639	0.00587	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—E2F1—ocular cancer	0.000638	0.00587	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CCND3—ocular cancer	0.00061	0.00561	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—HDAC1—ocular cancer	0.000555	0.0051	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—E2F1—ocular cancer	0.000555	0.0051	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—CDK2—ocular cancer	0.000551	0.00506	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—E2F1—ocular cancer	0.000526	0.00483	CbGpPWpGaD
Hydroxyurea—Pancytopenia—Dactinomycin—ocular cancer	0.000517	0.00921	CcSEcCtD
Hydroxyurea—Neutropenia—Dactinomycin—ocular cancer	0.000509	0.00907	CcSEcCtD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—CDK2—ocular cancer	0.000479	0.0044	CbGpPWpGaD
Hydroxyurea—Stomatitis—Dactinomycin—ocular cancer	0.000473	0.00843	CcSEcCtD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—E2F1—ocular cancer	0.000457	0.0042	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDK6—ocular cancer	0.000454	0.00418	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—CDK2—ocular cancer	0.000453	0.00417	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—RB1—ocular cancer	0.000453	0.00416	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—CDK4—ocular cancer	0.000452	0.00416	CbGpPWpGaD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—TP53—ocular cancer	0.000418	0.00384	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—CDK2—ocular cancer	0.000394	0.00362	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—RB1—ocular cancer	0.000393	0.00362	CbGpPWpGaD
Hydroxyurea—Chills—Dactinomycin—ocular cancer	0.000391	0.00697	CcSEcCtD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CCND2—ocular cancer	0.000391	0.00359	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—HDAC1—ocular cancer	0.000391	0.00359	CbGpPWpGaD
Hydroxyurea—Alopecia—Dactinomycin—ocular cancer	0.000385	0.00686	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDKN2C—ocular cancer	0.000383	0.00352	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S Transition—E2F1—ocular cancer	0.000381	0.00351	CbGpPWpGaD
Hydroxyurea—Erythema—Dactinomycin—ocular cancer	0.000379	0.00676	CcSEcCtD
Hydroxyurea—RRM2—E2F transcription factor network—RB1—ocular cancer	0.000373	0.00343	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—CDK4—ocular cancer	0.000372	0.00342	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—CDKN1B—ocular cancer	0.000352	0.00324	CbGpPWpGaD
Hydroxyurea—Ill-defined disorder—Dactinomycin—ocular cancer	0.000352	0.00627	CcSEcCtD
Hydroxyurea—Anaemia—Dactinomycin—ocular cancer	0.000351	0.00625	CcSEcCtD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDKN2B—ocular cancer	0.00035	0.00322	CbGpPWpGaD
Hydroxyurea—RRM2—Fluoropyrimidine Activity—TP53—ocular cancer	0.000344	0.00316	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CDKN2C—ocular cancer	0.000342	0.00315	CbGpPWpGaD
Hydroxyurea—Malaise—Dactinomycin—ocular cancer	0.000342	0.0061	CcSEcCtD
Hydroxyurea—Leukopenia—Dactinomycin—ocular cancer	0.000339	0.00605	CcSEcCtD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—MDM2—ocular cancer	0.000335	0.00308	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S Transition—CDK2—ocular cancer	0.000329	0.00302	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—CDKN1A—ocular cancer	0.000325	0.00299	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—RB1—ocular cancer	0.000324	0.00298	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.000322	0.00296	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—E2F1—ocular cancer	0.000321	0.00296	CbGpPWpGaD
Hydroxyurea—Discomfort—Dactinomycin—ocular cancer	0.000319	0.00569	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—E2F5—ocular cancer	0.000319	0.00293	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—E2F4—ocular cancer	0.000312	0.00287	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—MYBL2—ocular cancer	0.000312	0.00287	CbGpPWpGaD
Hydroxyurea—Oedema—Dactinomycin—ocular cancer	0.00031	0.00552	CcSEcCtD
Hydroxyurea—RRM1—E2F transcription factor network—EP300—ocular cancer	0.000309	0.00284	CbGpPWpGaD
Hydroxyurea—Infection—Dactinomycin—ocular cancer	0.000307	0.00548	CcSEcCtD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—CDKN1B—ocular cancer	0.000306	0.00281	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—RBL1—ocular cancer	0.000306	0.00281	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—E2F2—ocular cancer	0.000306	0.00281	CbGpPWpGaD
Hydroxyurea—Thrombocytopenia—Dactinomycin—ocular cancer	0.000303	0.0054	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.000296	0.00272	CbGpPWpGaD
Hydroxyurea—Anorexia—Dactinomycin—ocular cancer	0.000295	0.00526	CcSEcCtD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—CCND1—ocular cancer	0.000292	0.00268	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—CDKN1B—ocular cancer	0.00029	0.00267	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—E2F5—ocular cancer	0.000285	0.00262	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—CDKN1A—ocular cancer	0.000283	0.0026	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—RBL2—ocular cancer	0.000281	0.00258	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—E2F4—ocular cancer	0.000279	0.00257	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—MYBL2—ocular cancer	0.000279	0.00257	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDK2—ocular cancer	0.000277	0.00255	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—MDM2—ocular cancer	0.000276	0.00254	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—RBL1—ocular cancer	0.000274	0.00252	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—E2F2—ocular cancer	0.000274	0.00252	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S Transition—RB1—ocular cancer	0.00027	0.00249	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—MYC—ocular cancer	0.00027	0.00248	CbGpPWpGaD
Hydroxyurea—Decreased appetite—Dactinomycin—ocular cancer	0.000269	0.0048	CcSEcCtD
Hydroxyurea—RRM2—E2F transcription factor network—CDKN1A—ocular cancer	0.000268	0.00246	CbGpPWpGaD
Hydroxyurea—Fatigue—Dactinomycin—ocular cancer	0.000267	0.00476	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—RBBP4—ocular cancer	0.000265	0.00244	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—E2F3—ocular cancer	0.000265	0.00244	CbGpPWpGaD
Hydroxyurea—Pain—Dactinomycin—ocular cancer	0.000265	0.00472	CcSEcCtD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDK4—ocular cancer	0.000262	0.00241	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000255	0.00234	CbGpPWpGaD
Hydroxyurea—Feeling abnormal—Dactinomycin—ocular cancer	0.000255	0.00455	CcSEcCtD
Hydroxyurea—RRM2—E2F transcription factor network—EP300—ocular cancer	0.000255	0.00234	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PSPH—ocular cancer	0.000253	0.00233	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDC25A—ocular cancer	0.000252	0.00232	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—CDKN1B—ocular cancer	0.000252	0.00232	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—RBL2—ocular cancer	0.000251	0.00231	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—TFDP1—ocular cancer	0.000247	0.00227	CbGpPWpGaD
Hydroxyurea—Body temperature increased—Dactinomycin—ocular cancer	0.000245	0.00436	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000241	0.00222	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—CCND1—ocular cancer	0.000241	0.00221	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—E2F3—ocular cancer	0.000237	0.00218	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—RBBP4—ocular cancer	0.000237	0.00218	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	0.000234	0.00215	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—CDKN1A—ocular cancer	0.000233	0.00214	CbGpPWpGaD
Hydroxyurea—Hypersensitivity—Dactinomycin—ocular cancer	0.000228	0.00406	CcSEcCtD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—RB1—ocular cancer	0.000228	0.00209	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CDC25A—ocular cancer	0.000226	0.00207	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CCND3—ocular cancer	0.000224	0.00206	CbGpPWpGaD
Hydroxyurea—Asthenia—Dactinomycin—ocular cancer	0.000222	0.00396	CcSEcCtD
Hydroxyurea—RRM2—E2F transcription factor network—MYC—ocular cancer	0.000222	0.00204	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—TFDP1—ocular cancer	0.000221	0.00203	CbGpPWpGaD
Hydroxyurea—Diarrhoea—Dactinomycin—ocular cancer	0.000212	0.00377	CcSEcCtD
Hydroxyurea—RRM2—G1/S Transition—CDKN1B—ocular cancer	0.000211	0.00194	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PSPH—ocular cancer	0.000209	0.00192	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CCND3—ocular cancer	0.0002	0.00184	CbGpPWpGaD
Hydroxyurea—Vomiting—Dactinomycin—ocular cancer	0.000197	0.00351	CcSEcCtD
Hydroxyurea—Rash—Dactinomycin—ocular cancer	0.000195	0.00348	CcSEcCtD
Hydroxyurea—RRM2—G1/S Transition—CDKN1A—ocular cancer	0.000194	0.00179	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	0.000193	0.00177	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	0.000192	0.00177	CbGpPWpGaD
Hydroxyurea—Nausea—Dactinomycin—ocular cancer	0.000184	0.00328	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000179	0.00164	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDKN1B—ocular cancer	0.000177	0.00163	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CCND1—ocular cancer	0.000169	0.00156	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDK6—ocular cancer	0.000167	0.00153	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDKN1A—ocular cancer	0.000164	0.0015	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000163	0.0015	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S Transition—MYC—ocular cancer	0.000161	0.00148	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	0.000158	0.00146	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000156	0.00143	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000151	0.00138	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CDK6—ocular cancer	0.000149	0.00137	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000143	0.00132	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.000143	0.00132	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CCND2—ocular cancer	0.000143	0.00132	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—MYC—ocular cancer	0.000136	0.00125	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.000128	0.00118	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CCND2—ocular cancer	0.000128	0.00118	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—HDAC1—ocular cancer	0.000128	0.00118	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000125	0.00115	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000125	0.00115	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—E2F1—ocular cancer	0.000118	0.00108	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CDKN2B—ocular cancer	0.000115	0.00106	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—E2F1—ocular cancer	0.000105	0.000969	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000103	0.000943	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDK2—ocular cancer	0.000102	0.000935	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDK4—ocular cancer	9.61e-05	0.000884	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CDK2—ocular cancer	9.09e-05	0.000836	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	8.66e-05	0.000796	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CDK4—ocular cancer	8.59e-05	0.00079	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—RB1—ocular cancer	8.36e-05	0.000768	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GNA11—ocular cancer	7.98e-05	0.000733	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—RB1—ocular cancer	7.47e-05	0.000687	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GNAQ—ocular cancer	7.42e-05	0.000682	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GNA11—ocular cancer	6.57e-05	0.000604	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDKN1B—ocular cancer	6.51e-05	0.000598	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—MDM2—ocular cancer	6.37e-05	0.000586	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CCND1—ocular cancer	6.21e-05	0.000571	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GNAQ—ocular cancer	6.11e-05	0.000561	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDKN1A—ocular cancer	6e-05	0.000552	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CDKN1B—ocular cancer	5.82e-05	0.000535	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—EP300—ocular cancer	5.71e-05	0.000525	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CCND1—ocular cancer	5.55e-05	0.00051	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CDKN1A—ocular cancer	5.37e-05	0.000494	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—EP300—ocular cancer	5.11e-05	0.00047	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—MYC—ocular cancer	4.98e-05	0.000458	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—MYC—ocular cancer	4.45e-05	0.000409	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PSPH—ocular cancer	3.98e-05	0.000366	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—TP53—ocular cancer	3.66e-05	0.000336	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—EP300—ocular cancer	2.67e-05	0.000245	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—EP300—ocular cancer	2.19e-05	0.000202	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—AKT1—ocular cancer	1.61e-05	0.000148	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—AKT1—ocular cancer	1.33e-05	0.000122	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GNA11—ocular cancer	1.25e-05	0.000115	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GNAQ—ocular cancer	1.16e-05	0.000107	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—EP300—ocular cancer	4.18e-06	3.84e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—AKT1—ocular cancer	2.53e-06	2.32e-05	CbGpPWpGaD
